Maven Brands Inc (TRLFF)
0.01
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Maven Brands Total Assets (Quarterly): 3.725M for Dec. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 3.725M |
September 30, 2022 | 3.775M |
June 30, 2022 | 4.020M |
March 31, 2022 | 4.061M |
December 31, 2021 | 4.219M |
September 30, 2021 | 3.747M |
June 30, 2021 | 4.381M |
March 31, 2021 | 4.439M |
December 31, 2020 | 3.910M |
September 30, 2020 | 3.772M |
June 30, 2020 | 4.042M |
March 31, 2020 | 4.057M |
December 31, 2019 | 10.63M |
September 30, 2019 | 11.01M |
June 30, 2019 | 11.98M |
March 31, 2019 | 12.99M |
Date | Value |
---|---|
December 31, 2018 | 10.52M |
September 30, 2018 | 12.07M |
June 30, 2018 | 11.72M |
March 31, 2018 | 12.62M |
December 31, 2017 | 1.866M |
September 30, 2017 | 1.796M |
March 31, 2017 | 0.5786M |
December 31, 2016 | 0.7059M |
September 30, 2016 | 0.3561M |
June 30, 2016 | 0.4156M |
March 31, 2016 | 0.069M |
December 31, 2015 | 0.141M |
September 30, 2015 | 0.0377M |
June 30, 2015 | 0.0309M |
March 31, 2015 | 0.039M |
December 31, 2014 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.725M
Minimum
Dec 2022
11.98M
Maximum
Jun 2019
5.451M
Average
4.057M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.019M |
Shareholders Equity (Quarterly) | -1.294M |